NASDAQ : SRTS

Investor Relations

Company Overview

Sensus Healthcare, Inc. (NASDAQ: SRTS) is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™, SRT-100+™ and SRT-100 Vision™.

Latest News

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Management will discuss its new "Fair Deal Agreement" for its SRT-100 Vision™ IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th BOCA RATON, Fla., March 14, 2024 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company...

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company's booth generated a record-high number of sales leads and affirms very strong interest in a better economic...

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditionsIntroduces recurring revenue model for the SRT-100 Vision™ (IG-SRT) to address dermatologist demand Conference call begins at 4:30...

Stock Quote

Company

851 Broken Sound Parkway
Boca Raton, FL 33487
info@sensushealthcare.com

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071

Contact

Reception Phone Number: 561.922.5808
Reception Fax Number: 561.948.2071
Toll-free number: 800.324.9890
Email: info@sensushealthcare.com